Entering text into the input field will update the search result below

GeoVax presents COVID-19 vaccine data at World Vaccine & Immunotherapy Congress

Dec. 01, 2021 9:24 AM ETGeoVax Labs, Inc. (GOVX) StockBy: SA News Team

Coronavirus and DNA, virus mutation. New variant and strain of SARS CoV 2. Microscopic view.

Gilnature/iStock via Getty Images

  • GeoVax Labs' (NASDAQ:GOVX) Chief Scientific Officer, Mark J. Newman, discussed the company's vaccine design strategy for developing a universal SARS-CoV-2 vaccine and presented efficacy and immunogenicity data for the Company’s lead and first-generation vaccine candidate, GEO-CM02, which

Recommended For You

More Trending News

About GOVX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
GOVX--
GeoVax Labs, Inc.